Long-term bone density evaluation in cerebrotendinous xanthomatosis: Evidence of improvement after chenodeoxycholic acid treatment

Calcified Tissue International

Volumn 92, Issue 3, 2013, Pages 282-286

  Martini, Giuseppe ^a   Mignarri, Andrea ^a   Ruvio, Martina ^a   Valenti, Roberto ^a   Franci, Beatrice ^a   Puppo, Marina Del ^b   Federico, Antonio ^a   Nuti, Ranuccio ^a   Dotti, Maria Teresa ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

25 Hydroxyvitamin D; Bone mineral density; Cerebrotendinous xanthomatosis; Chenodeoxycholic acid; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; CHENODEOXYCHOLIC ACID; CHOLESTANOL;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MASS; CEREBROTENDINOUS XANTHOMATOSIS; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

EID: 84873744151     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-012-9677-3     Document Type: Article

References (18)

1. Federico A, Dotti MT (2003) Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 18:633-638
2. Berginer VM, Salen G, Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649-1652
3. Berginer VM, Shany S, Alkalay D, Berginer J, Dekel S, Salen G, Tint GS, Gazit D (1993) Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 42:69-74
4. Federico A, Dotti MT, Loré F, Nuti R (1993) Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci 115:67-70
5. Chang WN, Lui CC (1997) Failure in the treatment of long-standing osteoporosis in cerebrotendinous xanthomatosis. J Formos Med Assoc 96:225-227
6. Cioncoloni D, Piu P, Tassi R, Acampa M, Guideri F, Taddei S, Bidelli S, Martini G, Mazzocchio R (2012) Relationship between the modified Rankin Scale and Barthel index in the process of functional recovery after stroke. NeuroRehabilitation 30:315-322
7. Bucciarelli P, Martini G, Martinelli I, Ceccarelli E, Gennari L, Bader R, Valenti R, Franci B, Nuti R, Mannucci PM (2010) The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. Eur J Intern Med 21:301-305
8. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S (2008) International Society for Clinical Densitometry 2007 adult and pediatric official positions. Bone 43:1115-1121
9. Katzman DK, Bachrach LK, Carter DR, Marcus R (1991) Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 73:1332-1339
10. Koopman BJ, van der Molen JC, Wolthers BG, de Jager AE, Waterreus RJ, Gips CH (1984) Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis). Clin Chim Acta 137:305-315
11. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266-281
12. Miki H, Takeuchi H, Yamada A, Nishioka M, Matsuzawa Y, Hamamoto I, Hiwatashi A, Ichikawa Y (1986) Quantitative analysis of the mitochondrial cytochrome P-450-linked monooxygenase system: NADPH-hepatoredoxin reductase, hepatoredoxin, and cytochrome P-450s27 in livers of patients with cerebrotendinous xanthomatosis. Clin Chim Acta 160:255-263
13. Kuriyama M, Fujiyama J, Kubota R, Nakagawa M, Osame M (1993) Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 42:1497-1498
14. Väänänen HK (1991) Pathogenesis of osteoporosis. Calcif Tissue Int 49:S11-S14
15. Henry YM, Fatayerji D, Eastell R (2004) Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 15:263-273
16. Mignarri A, Rossi S, Ballerini M, Gallus GN, Del Puppo M, Galluzzi P, Federico A, Dotti MT (2011) Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis. J Neurol 258:783-790
17. Pilo de la Fuente B, Sobrido MJ, Girós M, Pozo L, Lustres M, Barrero F, Macarrón J, Díaz M, Jiménez-Escrig A (2011) Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis. Neurologia 26:397-404
18. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362-371